The CEO of a California biotechnology company was sentenced today to seven years in prison for a securities fraud scheme that resulted in approximately $28 million in investor losses and obstruction of a related U.S. Securities and Exchange Commission (SEC) investigation. Read More
Home » Biotech CEO Sentenced for $28M COVID-19 Securities Fraud Scheme and Obstruction of Related Investigation
Biotech CEO Sentenced for $28M COVID-19 Securities Fraud Scheme and Obstruction of Related Investigation
Related Posts
Gambian Man, First Non-U.S. National Convicted of Torture, Sentenced
Michael Sang Correa, 46, was sentenced today to 810 months in prison by Senior Judge Christine M. Arguello for the District of Colorado after being… BronGambian Man, First Non-U.S. National Convicted of Torture, Sentenced
Florida Man Sentenced to Over Six Years for Witness Retaliation
A Florida man was sentenced today to six years and 10 months in prison for assaulting an individual in retaliation for testimony that the victim… BronFlorida Man Sentenced to Over Six Years for Witness Retaliation
California Man Pleads Guilty for Role in $15.9M COVID-19 Fraud Scheme
A California man pleaded guilty yesterday for his role in a scheme to defraud the Small Business Administration (SBA) out of $15.9 million in loans… BronCalifornia Man Pleads Guilty for Role in $15.9M COVID-19 Fraud Scheme